Learn more

UNIV HEIDELBERG RUPRECHT KARLS

Overview
  • Total Patents
    117
  • GoodIP Patent Rank
    17,034
  • Filing trend
    ⇩ 39.0%
About

UNIV HEIDELBERG RUPRECHT KARLS has a total of 117 patent applications. It decreased the IP activity by 39.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FUNDACIO INST DINVESTIGACIO BIOMEDICA DE BELLVITGE IDIBELL, TARGOVAX ASA and INST PASTEUR SHANGHAI CAS.

Patent filings per year

Chart showing UNIV HEIDELBERG RUPRECHT KARLSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mier Walter 17
#2 Urban Stephan 13
#3 Haberkorn Uwe 12
#4 Gdynia Georg 12
#5 Burwinkel Barbara 10
#6 Katus Hugo 8
#7 Von Knebel-Doeberitz Magnus 7
#8 Müller Oliver 7
#9 Roth Wilfried 6
#10 Sauter Max 6

Latest patents

Publication Filing date Title
IL263421D0 Means and methods for diagnosing heart failure in a subject
CN111356482A Dual-labeled probe for molecular imaging and uses thereof
CN111132993A Rationally designed virus-like particles for modulating Chimeric Antigen Receptor (CAR) -T cell therapy
WO2018189244A1 Adeno-associated virus library
EP3585799A1 Polypeptide with tumour binding activity
US2019282700A1 Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels
EP3534930A1 Wnt antagonists and their use in methods for treating myocardial infarction
US2020051778A1 Microtome, scanning electron microscope and method for preparing thin slices from a sample and method for analysing thin slices produced from a sample in a scanning electron microscope and use of a magnetic tape for the purpose of depositing and transporting of thin slices of samples in the field of scanning electron microscopy
US2019351069A1 Coating of Nanoparticle Surfaces with Cyclopeptides for Improving Delivery of Agents Via the Oral Route
US2019194756A1 Gene panel specific for pulmonary hypertension and its uses
EP3445852A1 Means and methods for inactivating therapeutic dna in a cell
CA3007877A1 Combined preparations of pkm2 modulators and hmgb1
JP2018078802A Measles virus encoding tumor antigen
US2018221479A1 Agents for use in the treatment of glioma
JP2016028025A Msi-specific frameshift peptides (fsp) for prevention and treatment of cancer
CN106460052A Synthesis of double-stranded nucleic acids
EP2988129A1 Method and kit for assessment of sodium channel-related anti- or pro-arrhythmic potential of compounds
EP3409794A1 Circulating mirnas as early detection marker and prognostic marker
US2016108376A1 ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases
US2015297742A1 Conjugates of proteins and multivalent cell-penetrating peptides and their uses